NCT01932437View on ClinicalTrials.gov

Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 26, 2013

Primary Completion Date

July 3, 2014

Study Completion Date

July 3, 2014

Conditions
Inhalational Anthrax
Interventions
BIOLOGICAL

ETI-204

monoclonal antibody

OTHER

Placebo

Placebo for ETI-204

Trial Locations (1)

75247

Covance Clinical Research Unit Inc., Dallas

Sponsors
All Listed Sponsors
lead

Elusys Therapeutics

OTHER

NCT01932437 - Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers | Biotech Hunter | Biotech Hunter